Vyant Bio Announces Participation at the 2022 CDKL5 Forum Hosted by the Loulou Foundation on November 7-8, 2022
27 oct. 2022 17h10 HE
|
Vyant Bio, Inc.
Platform and Poster Presentations on Vyant Bio’s Human First Drug Discovery Platform and Progress on CDKL5 Deficiency Disorder (CDD) CHERRY HILL, N.J., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Vyant...
Global Mesenchymal Stem Cells (MSC) Advances and Applications Market Report 2022 with Company Profiles for 98 MSC Market Competitors, Including their Proprietary Technologies and Products/Services
05 sept. 2022 07h43 HE
|
Research and Markets
Dublin, Sept. 05, 2022 (GLOBE NEWSWIRE) -- The "Mesenchymal Stem Cells - Advances and Applications, 2022" report has been added to ResearchAndMarkets.com's offering. Today, nearly one-hundred...
Induced Pluripotent Stem Cell (iPSC) Global Market to Reach $3.57 Billion by 2026
01 août 2022 05h13 HE
|
Research and Markets
Dublin, Aug. 01, 2022 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Global Market Report 2022, By Derived Cell Type, By Application, By End-User" report has been added to...
Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Surging Number of Preclinical and Physician-led Studies and Formal Clinical Trials Presents Opportunities
11 juil. 2022 07h33 HE
|
Research and Markets
Dublin, July 11, 2022 (GLOBE NEWSWIRE) -- The "Global Induced Pluripotent Stem Cell (iPSC) Industry Report, 2022" report has been added to ResearchAndMarkets.com's offering. Since the discovery of...
Global Stem Cell Assays Market Projected to Reach $4.5 Billion by 2027
06 juil. 2022 07h18 HE
|
Research and Markets
Dublin, July 06, 2022 (GLOBE NEWSWIRE) -- The "Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product &...
Global Induced Pluripotent Stem Cell (iPSC) Market Share, Size, Trends, Industry Analysis & Forecasts, 2017-2020 & 2021-2028
16 nov. 2021 06h03 HE
|
Research and Markets
Dublin, Nov. 16, 2021 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Market Share, Size, Trends, Industry Analysis Report By Application (Manufacturing, Academic Research, Drug...
Global Stromal Vascular Fraction Market Report 2021: Market to Reach $97.6 Million by 2026 - Extensive Therapeutic Scope Set to Stimulate Growth of the Market
11 nov. 2021 04h18 HE
|
Research and Markets
Dublin, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The "Stromal Vascular Fraction - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Stromal...
Evelyn D’An Joins Cytovia Therapeutics as Chief Financial Officer
12 oct. 2021 12h24 HE
|
Cytovia Therapeutics
AVENTURA, Fla., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, Inc. (“Cytovia”), a biopharmaceutical company developing allogeneic “off-the-shelf” gene-edited iNK and CAR (Chimeric Antigen...
Bone Therapeutics signe un partenariat de recherche avec Implant Therapeutics pour garantir son accès à des Cellules Souches Pluripotentes induites (CSPi)
28 sept. 2021 01h00 HE
|
Bone Therapeutics SA
INFORMATION REGLEMENTEE Bone Therapeutics bénéficiera de l’expertise d’Implant Therapeutics et pourra accéder à des lignées cellulaires Souches Pluripotentes induites (SPi), incluant des...
Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)
28 sept. 2021 01h00 HE
|
Bone Therapeutics SA
REGULATED INFORMATION Bone Therapeutics will gain access to iPS cell lines, including hypoimmunogenic cell lines, differentiation protocols and expertise iPSC technology allows for the...